Becton Dickinson (BDX)  announced Sunday, April 23, that it will acquire medical technology peer C.R. Bard (BCR)  for $24 billion, the largest-ever deal for the 120-year-old buyer. Both BD and Bard are century-old medical device companies based in northern New Jersey.

Bard shareholders will receive $222.93 in cash and 0.5077 shares of BD stock per Bard share, or $317 per Bard share based on BD's closing price Friday of $185.29. The purchase price represents a 25.3% premium over Bard's Friday closing price of $253.07.

READ MORE: Becton Dickinson Acquires Medical Technology Peer C.R. Bard for Hefty Premium

This article was written by a staff member of TheStreet.

More from Video

History With a Side of Fries? Inside McDonald's Storied Past

History With a Side of Fries? Inside McDonald's Storied Past

Rewind: Jim Cramer's Reveals His Concern About Earnings Season

Rewind: Jim Cramer's Reveals His Concern About Earnings Season

Market of the Week: E-mini S&P 500

Market of the Week: E-mini S&P 500

China's Landmark Day Headlines An Earnings Bonanza: What to Watch This Week

China's Landmark Day Headlines An Earnings Bonanza: What to Watch This Week

Tinley CEO Jeff Maser Breaks Down the Beverage Industry

Tinley CEO Jeff Maser Breaks Down the Beverage Industry